Skip to content

瑞维蒂

US · RVTY #1032 按市值排名 上市于 1970
152.64 -2.07 -1.34%
实时 - 追踪5344个代码 - 心跳于22秒前 · 2026-10-16 19:30

关于 Revvity

Revvity, Inc. 提供 health science 解决方案, technologies, expertise, and 服务 that deliver complete workflows from discovery to 开发, and diagnosis to cure. It 专注于 translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm 运营 through the following 部分: Life Sciences and Diagnostics. The Life Sciences 部分 delivers innovative 解决方案 to optimize workflows, boost productivity, and accelerate drug discovery and 开发. The Diagnostics 部分 提供 instruments, reagents, assay 平台, and 软件 to 医疗保健 and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was 成立 on April 19, 1937 and is 总部位于 in Waltham, MA.

成立时间
1937
首席执行官
Dr. Prahlad R. Singh, PhD
员工人数
11,000
总部地址
Waltham, Massachusetts, United States of America
财年结束日
12-27
官方网站
revvity.com

公司概况

交易所
US
股票代码
RVTY
市值排名
#1032
上市日期
1970-01-01
市值
17.03B
流通市值
15.64B
总股数
111.59M
流通股数
102.49M

行业与主题板块

Diagnostics & Research Fractional Shares JP

浏览全部行业与主题板块

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

瑞维蒂 讨论区 0 条评论

发表评论